Related Experiment Videos
Communicating synergism in drug combination studies
1Lilly Research Laboratories, Lilly Corporate Center, Eli Lilly and Company, Indianapolis, Indiana, USA. Jesse_Brodkin@merck.com
Arzneimittel-Forschung
|September 20, 2000
Summary
This study introduces two new methods to quantify drug synergism using isobolograms, moving beyond qualitative assessments. These techniques help determine optimal drug ratios and the extent of synergistic effects in combination therapies.
Area of Science:
- Pharmacology
- Drug Discovery
- Quantitative Analysis
Background:
- Isobolograms are standard for assessing drug synergism qualitatively.
- Traditional methods lack quantitative precision for synergistic drug effects.
Purpose of the Study:
- To develop and describe two quantitative procedures for analyzing drug synergism based on isobolographic plots.
- To provide a method for estimating optimal drug ratios and the degree of dose synergism.
Main Methods:
- Utilizing the derivative of the isobolar curve to estimate the optimal dose ratio.
- Calculating the axis intercept of the tangent to the isobolar curve for quantifying expected dose synergism.
- Expressing effect potentiation by comparing observed effects to purely additive effects.
Main Results:
- The derivative method provides an estimate of the optimal drug dose ratio for synergistic interactions.
- The tangent intercept method quantifies the extent of expected dose synergism.
- A ratio of observed to expected additive effects measures the degree of potentiation.
Conclusions:
- The described procedures offer direct, non-statistical means to quantify drug synergism.
- These methods enhance the communication of synergistic actions in drug combination studies.
- Quantitative isobolographic analysis improves understanding of combined drug effects.